{"behavior":"degenerate_repetition","label_filter":null,"limit":10,"next_offset":12205,"offset":12195,"previous_offset":null,"rows":[{"assistant_initiates":false,"asst_text":"**Question:** Usual locations of **seborrheic eczema (seborrheic dermatitis)**.\n\n---\n\n**Seborrheic dermatitis** typically affects areas rich in sebaceous glands.\n\n**Common locations:**\n\n- **Scalp (e)** \u2014 classic location (dandruff, scaling patches).  \n- **Face (d)** \u2014 especially nasolabial folds, eyebrows, eyelids.  \n- **Upper trunk (c)** \u2014 often involves upper chest and back.\n\n**Less typical/uncommon locations:**\n\n- **Hands (a)** \u2014 not usual for seborrheic dermatitis.  \n- **Feet (b)** \u2014 uncommon.\n\n---\n\n### Correct answers:  \n**c. Upper trunk**  \n**d. Face**  \n**e. Scalp**","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":719,"n_turns_in_conversation":21,"n_words":101,"source_row_offset":12195,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"0519e96215a99237ab837f5c","turn_index":6,"user_text":"Usual locations of seborrheic eczema (dermatitis) are:\nQuestion 6 Select one or more:\n\na.\nHands\n\nb.\nFeet\n\nc.\nUpper trunk\n\nd.\nFace\n\ne.\nScalp"},{"assistant_initiates":false,"asst_text":"**Question:** Treatment of **epidermolysis bullosa** includes:\n\n---\n\n**Epidermolysis bullosa (EB)** is a group of genetic disorders characterized by skin fragility and blister formation due to minor trauma.\n\n**Key points in treatment:**\n\n- Mainly **supportive and preventive**.  \n- **Preventing trauma** to reduce blister formation is critical.  \n- Symptomatic treatment includes wound care, infection prevention, and managing itching.\n\n---\n\n**Option analysis:**\n\n- **a. Steroids**  \n  - Generally **not routinely used** as they may worsen skin fragility and delay healing.\n\n- **b. Antihistamines**  \n  - Can be used to relieve **itching**, which may help reduce trauma from scratching.\n\n- **c. Trauma prevention**  \n  - **Absolutely essential** to minimize blister formation.\n\n- **d. Non-steroidal anti-inflammatory drugs (NSAIDs)**  \n  - Can be used for **pain and inflammation control**.\n\n- **e. Anabolic preparations**  \n  - Not standard treatment for EB.\n\n---\n\n### **Correct answers:**  \n**b. Antihistamines**  \n**c. Trauma prevention**  \n**d. Non-steroidal anti-inflammatory drugs**\n\n---\n\n**Summary:** Treatment of EB is mainly supportive, focusing on trauma prevention, symptom control (itch and pain), and wound care. Steroids and anabolic agents are not typical treatments.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1480,"n_turns_in_conversation":21,"n_words":195,"source_row_offset":12196,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"055cd8c1496a47df469b51af","turn_index":7,"user_text":"Treatment of epidermolysis bullosa includes:\nQuestion 7 Select one or more:\n\na.\nSteroids\n\nb.\nAntihistamines\n\nc.\nTrauma prevention\n\nd.\nNon-steroidal anti-inflammatory drugs\n\ne.\nAnabolic preparations"},{"assistant_initiates":false,"asst_text":"**Question:** Distinctive clinical features of **herpes zoster** are:\n\n---\n\n**Herpes zoster** (shingles) is caused by reactivation of varicella-zoster virus, characterized by:\n\n- **Painful** skin lesions (often preceding the rash).  \n- **Asymmetrical** distribution, typically following a dermatome.  \n- **Grouped vesicles** on an erythematous base.\n\n---\n\nLet's analyze the options:\n\n- **a. Painful symmetrical grouped vesicles, no erythema**  \n  - Incorrect: lesions are **asymmetrical**, and erythema is typically present.\n\n- **b. Painless symmetrical isolated vesicles, erythema**  \n  - Incorrect: usually **painful**, usually **grouped**, and **asymmetrical**.\n\n- **c. Painless asymmetrical erythema, no vesicles**  \n  - Incorrect: vesicles are a hallmark.\n\n- **d. Painful asymmetrical grouped vesicles, erythema**  \n  - Correct: classic description of herpes zoster.\n\n- **e. All the variants are possible**  \n  - Incorrect.\n\n---\n\n### **Correct answer:**  \n**d. Painful asymmetrical grouped vesicles, erythema**","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1331,"n_turns_in_conversation":21,"n_words":169,"source_row_offset":12197,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"4f6e51d9c230d2b28c933c7e","turn_index":8,"user_text":"Distinctive clinical features of herpes zoster are:\nQuestion 8 Select one:\n\na.\nPainful symmetrical grouped vesicles, no erythema\n\nb.\nPainless symmetrical isolated vesicles, erythema\n\nc.\nPainless asymmetrical erythema, no vesicles\n\nd.\nPainful asymmetrical grouped vesicles, erythema\n\ne.\nAll the variants are possible"},{"assistant_initiates":false,"asst_text":"**Question:** Organ that is **NOT** affected by **lepromatous leprosy**.\n\n---\n\n**Lepromatous leprosy** is a multibacillary form of leprosy caused by *Mycobacterium leprae*, characterized by widespread skin lesions and involvement of several organs and tissues, including:\n\n- **Bones** \u2014 affected due to nerve damage and direct invasion \u2192 **Yes, affected**.  \n- **Testicles** \u2014 common site of involvement causing atrophy \u2192 **Yes, affected**.  \n- **Eyes** \u2014 involvement leading to keratitis, iritis, and blindness \u2192 **Yes, affected**.  \n- **Lungs** \u2014 usually **NOT affected** by *M. leprae*. Respiratory system is not a typical target in lepromatous leprosy.  \n- **Liver** \u2014 generally not involved in lepromatous leprosy.\n\nBetween lungs and liver, the liver is also typically spared, but lungs especially are rarely involved.\n\n---\n\n### Considering the most correct answer:\n\n**d. Lungs**\n\n---\n\n### **Correct answer:**  \n**d. Lungs**","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1056,"n_turns_in_conversation":21,"n_words":155,"source_row_offset":12198,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"6067aca879828d978f68dbe5","turn_index":9,"user_text":"Organ that is NOT affected by lepromatous leprosy:\nQuestion 9 Select one:\n\na.\nBones\n\nb.\nTesticles\n\nc.\nEyes\n\nd.\nLungs\n\ne.\nLiver"},{"assistant_initiates":false,"asst_text":"**Question:** Method that allows diagnosing **head pediculosis** (head lice infestation):\n\n---\n\n**Head pediculosis** is diagnosed by identifying lice or their eggs (nits) on the scalp or hair shafts.\n\nLet's analyze the options:\n\n- **a. Iodine test**  \n  - Not typically used for diagnosing pediculosis.\n\n- **b. Culture**  \n  - Lice do not grow in culture; this is not a diagnostic method.\n\n- **c. Unaided eye examination**  \n  - Possible but often difficult, especially for nits. Can miss some infestations.\n\n- **d. Positive intracutaneous allergic test**  \n  - Not applicable for diagnosis.\n\n- **e. Microscopy**  \n  - Examining hair or scalp scrapings under a microscope is a **accurate** method to detect lice or nits.\n\n---\n\n### However, in practical clinical settings:\n\n- **Unaided eye examination** is often the first and usual method, by looking closely at hair and scalp.\n\n- **Microscopy** confirms or aids diagnosis, especially to differentiate nits from dandruff or scales.\n\n---\n\n### Most suitable answer:\n\n**e. Microscopy**\n\n---\n\n### **Correct answer:**\n\n**e. Microscopy**","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1270,"n_turns_in_conversation":21,"n_words":187,"source_row_offset":12199,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"1ae1769afa2cd53073c96013","turn_index":10,"user_text":"Method that allows diagnosing of head pediculosis: \nQuestion 10 Select one:\n\na.\nIodine test\n\nb.\nCulture\n\nc.\nUnaided eye examination\n\nd.\nPositive intracutaneous allergic test\n\ne.\nMicroscopy"},{"assistant_initiates":false,"asst_text":"**Question:** Types of ichthyosis that have **intrauterine clinical manifestations**.\n\n---\n\n**Background:**  \nSome severe types of ichthyosis show clinical signs already in utero **(intrauterine)**, such as abnormal skin shedding, thickened skin, or characteristic deformities detectable by ultrasound or at birth.\n\n---\n\n### Analysis of options:\n\n- **a. \u201cHarlequin\u201d ichthyosis**  \n  - Severe, lethal form with thick, armor-like skin present at birth, with **intrauterine manifestations** including fetal skin abnormalities detectable by prenatal imaging.  \n  - **Yes**, intrauterine manifestations.\n\n- **b. X-linked ichthyosis**  \n  - Usually presents after birth or in early infancy; **no significant intrauterine signs**.  \n  - **No** intrauterine manifestations.\n\n- **c. Ichthyosis vulgaris**  \n  - Mild form, usually appears in early childhood, not intrauterine.  \n  - **No**.\n\n- **d. Lamellar ichthyosis**  \n  - Severe congenital ichthyosis often presenting at birth with thick scales; some cases show signs late in pregnancy.  \n  - **Yes**, may have intrauterine manifestations.\n\n- **e. Epidermolytic ichthyosis**  \n  - Presents at birth with blistering and erythroderma, may show skin fragility and peeling **already at birth**; intrauterine signs possible but less well defined. Some literature suggests possible intrauterine changes.  \n  - Generally considered **yes** for prenatal manifestation.\n\n---\n\n### **Correct answers:**  \n**a. \u201cHarlequin\u201d ichthyosis**  \n**d. Lamellar ichthyosis**  \n**e. Epidermolytic ichthyosis**\n\n---\n\n### Summary:  \n- Harlequin ichthyosis is the classic ichthyosis with distinct intrauterine manifestations.  \n- Lamellar and epidermolytic ichthyosis also can have signs evident at or shortly after birth, sometimes detectable before birth.  \n- X-linked and ichthyosis vulgaris typically do not show prenatal manifestations.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":2089,"n_turns_in_conversation":21,"n_words":266,"source_row_offset":12200,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"ba20a22ae79c851c8ec9a948","turn_index":11,"user_text":"Types of ichthyosis that have intrauterine clinical manifestations:\nQuestion 11 Select one or more:\n\na.\n\u201cHarlequine\u201d ichthyosis\n\nb.\nX-linked ichthyosis\n\nc.\nIchthyosis vulgaris\n\nd.\nLamellar ichthyosis\n\ne.\nEpidermolytic ichthyosis"},{"assistant_initiates":false,"asst_text":"**Question:** Treatment of **vulgar psoriasis** typically includes:\n\n---\n\n**Vulgar psoriasis** (plaque psoriasis) treatment involves various modalities, mainly:\n\n- **Topical treatments** for mild to moderate disease.  \n- **Systemic treatments** (immunosuppressants, cytostatics) for severe or resistant cases.  \n- **Avoid systemic steroids** generally, as they can cause rebound or exacerbation.  \n- Antibiotics are **not routinely used** unless there is secondary infection.  \n- Topical vitamin D analogs and steroids are mainstays.\n\n---\n\n### Option analysis:\n\n- **a. Systemic steroids**  \n  - Generally **not recommended** due to risk of severe rebound psoriasis.\n\n- **b. Cytostatics** (e.g., methotrexate, cyclosporine)  \n  - Used in **moderate to severe cases**.  \n  - **Yes**, included in typical treatment.\n\n- **c. Topical and systemic antibiotics**  \n  - Not typical unless secondary infection occurs.  \n  - **No** as standard treatment.\n\n- **d. Topical vitamin D** (e.g., calcipotriol)  \n  - Widely used and effective topical treatment.  \n  - **Yes**.\n\n- **e. Topical steroids**  \n  - Mainstay of topical therapy.  \n  - **Yes**.\n\n---\n\n### **Correct answers:**  \n**b. Cytostatics**  \n**d. Topical vitamin D**  \n**e. Topical steroids**\n\n---\n\n### Summary:  \n- Topical steroids and vitamin D analogs are first-line topical treatments.  \n- Cytostatics (systemic) are used for more severe disease.  \n- Systemic steroids and antibiotics are generally not part of routine psoriasis treatment.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1692,"n_turns_in_conversation":21,"n_words":228,"source_row_offset":12201,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"4f1c706e1683d801e021c5e5","turn_index":12,"user_text":"Treatment of vulgar psoriasis typically includes:\nQuestion 12 Select one or more:\n\na.\nSystemic steroids\n\nb.\nCytostatics\n\nc.\nTopical and systemic antibiotics\n\nd.\nTopical vitamin D\n\ne.\nTopical steroids"},{"assistant_initiates":false,"asst_text":"**Question:** Clinical types of **onychomycosis (tinea unguium)** **do NOT** include:\n\n---\n\n**Onychomycosis** has several recognized clinical types:\n\n- **Distal-lateral subungual onychomycosis (DLSO)** \u2014 most common type, affecting distal/lateral nail.  \n- **White superficial onychomycosis (WSO)** \u2014 white patches on the nail surface.  \n- **Proximal subungual onychomycosis (PSO)** \u2014 affects proximal nail fold, common in immunocompromised.  \n- **Endonyx onychomycosis** (sometimes called \"profund\" or \"profound\" type), involves invasion of the nail plate without subungual hyperkeratosis.  \n- **Hypertrophic type** \u2014 nails become thickened and distorted due to fungal infection.\n\n**Note:** \"Profound\" (c) is not a standard term used in classification of onychomycosis \u2014 the correct term is **Endonyx** type.\n\n---\n\n### Option Review:\n\n- **a. Hypertrophic** \u2014 recognized manifestation due to thickened nails.  \n- **b. Proximal type** \u2014 recognized.  \n- **c. Profound** \u2014 **NOT a typical clinical type** nomenclature; possibly a mistranslation or incorrect term.  \n- **d. Distal-lateral type** \u2014 recognized.  \n- **e. White superficial type** \u2014 recognized.\n\n---\n\n### **Correct answer:**  \n**c. Profound**\n\n---\n\n**Summary:**  \nAll options except \"Profound\" accurately represent clinical types or manifestations of onychomycosis.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1512,"n_turns_in_conversation":21,"n_words":201,"source_row_offset":12202,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"cd86aae11cc32d9192604a79","turn_index":13,"user_text":"Clinical types of onychomycosis (tinea unguinum) do not include:\nQuestion 13 Select one:\n\na.\nHypertrophic\n\nb.\nProximal type\n\nc.\nProfound\n\nd.\nDistal-lateral type\n\ne.\nWhite superficial type"},{"assistant_initiates":false,"asst_text":"**Question:** Transformation into scars can be characteristic for:\n\n---\n\nLet's analyze each option regarding the potential for **scar formation**:\n\n- **a. Erosion**  \n  - Partial loss of the epidermis only; usually *does not* scar because the dermis remains intact.  \n  - **No**, erosion typically heals without scarring.\n\n- **b. Superficial excoriation**  \n  - Minor skin trauma limited to epidermis, heals without scarring.  \n  - **No**, no scarring.\n\n- **c. Ulcer**  \n  - Loss of both epidermis and dermis, sometimes deeper tissue; healing usually involves scar formation.  \n  - **Yes**, ulcers typically scar.\n\n- **d. Papule**  \n  - Solid, elevated lesion, usually no tissue loss.  \n  - **No**, does not scar.\n\n- **e. Vegetation**  \n  - Hyperplastic or proliferative lesions, may heal with scarring depending on cause and extent, but not typically described as scarring lesion per se.  \n  - Less characteristic.\n\n---\n\n### **Correct answer:**  \n**c. Ulcer**\n\n---\n\n**Summary:** Scarring commonly occurs after **ulcers** due to deeper skin loss. Erosions and superficial excoriations heal without scars.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1257,"n_turns_in_conversation":21,"n_words":178,"source_row_offset":12203,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"90cca9afc379836041d040a5","turn_index":14,"user_text":"Transformation into scars can be characteristic for:\nQuestion 14 Select one:\n\na.\nErosion\n\nb.\nSuperficial excoriation\n\nc.\nUlcer\n\nd.\nPapule\n\ne.\nVegetation"},{"assistant_initiates":false,"asst_text":"**Question:** Acyclovir dosing in case of **herpes simplex** should be:\n\n---\n\n**Standard oral dosing for herpes simplex (e.g., HSV labialis, genital herpes) in adults** is:\n\n- **Acyclovir 200 mg orally, 5 times daily** for 5 days (typical treatment course).\n\nHigher doses like 800 mg or 400 mg are not standard for herpes simplex; 600 mg twice daily is more for herpes zoster.\n\n---\n\n### Review of options:\n\n- **a. 800 mg 5 times a day** \u2014 Higher than usual dose, not standard for HSV.  \n- **b. 200 mg 5 times a day** \u2014 Correct standard dose for HSV.  \n- **c. 600 mg twice daily** \u2014 Used in herpes zoster treatment.  \n- **d. 200 mg twice daily** \u2014 Too low frequency for HSV treatment.  \n- **e. 400 mg 5 times a day** \u2014 Not standard.\n\n---\n\n### **Correct answer:**  \n**b. 200 mg 5 times a day**\n\n---\n\n**Summary:**  \nAcyclovir 200 mg five times daily is the standard oral dose for treating herpes simplex infections.","behavior":"degenerate_repetition","conversation_hash":"40039b900cf09d442d92315f97650a12","conversation_redacted":false,"conversation_toxic":false,"country":"Belarus","empty_output":false,"evidence_codes":[],"label":"absent","label_present":false,"label_qualified":false,"label_source":"Final dense release","language":"English","model":"gpt-4.1-mini-2025-04-14","n_chars":1114,"n_turns_in_conversation":21,"n_words":207,"source_row_offset":12204,"source_shard":"turns-00079.parquet","timestamp":"Mon, 12 May 2025 01:09:31 GMT","turn_id":"3b8626d551e27bef1a99a92d","turn_index":15,"user_text":"Acyclovir in case of herpes simplex should be indicated:\nQuestion 15 Select one:\n\na.\n800 mg 5 times a day\n\nb.\n200 mg 5 times a day\n\nc.\n600 mg twice daily\n\nd.\n200 mg twice daily\n\ne.\n400 mg 5 times a day"}],"shard":{"index":79,"name":"turns-00079.parquet","rows":46297}}